Back to ALL Research Publications
PUBLICATION_
PUBLICATION_
PUBLICATION_
PUBLICATION_
Research Category: ,
Bacterial fluorescence imaging as a predictor of skin graft integration in burn wounds
Related Publications
Related Material
PUBLICATION_ Prospective clinical study on the efficacy of bacterial removal with mechanical debridement in and around chronic leg ulcers assessed with fluorescence imaging
PUBLICATION_ Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage
PUBLICATION_ A prospective multi-site observational study incorporating bacterial fluorescence information into the UPPER/LOWER wound infection checklists
PUBLICATION_ Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.








